Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 5Phase 3 4Phase 1/2 4Phase 4 3Phase 1 3Phase EARLY_PHASE1 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

INDUSTRY 147OTHER 132NETWORK 30NIH 23OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1fosaprepitant 1Tropisetron 1Olanzapine 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Multiple Myeloma × Clear all
NCT07413809 2026-02-17

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
92 enrolled
Plasma cell

Multiple Myeloma

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
99 enrolled
Plasma cell

Multiple Myeloma

NCT00872352 2009-03-31

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

Wolfson Medical Center

Phase 3 Unknown
30 enrolled
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00207805 2009-01-27

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Centre National de Greffe de Moelle Osseuse

Phase 3 Completed
202 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡